scholarly journals Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

1996 ◽  
Vol 98 (12) ◽  
pp. 2729-2738 ◽  
Author(s):  
C Serradeil-Le Gal ◽  
C Lacour ◽  
G Valette ◽  
G Garcia ◽  
L Foulon ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
Orally Active ◽  
V2 Receptor Antagonist

CHARACTERIZATION OF RWJ-351647, A NOVEL NONPEPTIDE VASOPRESSIN V2 RECEPTOR ANTAGONIST

2006 ◽  
Vol 33 (4) ◽  
pp. 320-326 ◽  
Author(s):  
Joseph W Gunnet ◽  
Jay M Matthews ◽  
Bruce E Maryanoff ◽  
Lawrence de Garavilla ◽  
Patricia Andrade-Gordon ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1992 ◽  
Vol 105 (4) ◽  
pp. 787-791 ◽  
Author(s):  
Yoshitaka Yamamura ◽  
Hidenori Ogawa ◽  
Hiroshi Yamashita ◽  
Tomihiko Chihara ◽  
Hisashi Miyamoto ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals Tolvaptan, an Orally Active Vasopressin V2-Receptor Antagonist-Pharmacology and Clinical Trials

2007 ◽  
Vol 25 (1) ◽  
pp. 1-13 ◽  
Author(s):  
Toshiki Miyazaki ◽  
Hiroyuki Fujiki ◽  
Yoshitaka Yamamura ◽  
Shigeki Nakamura ◽  
Toyoki Mori
Keyword(s):  
Clinical Trials ◽  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
Orally Active ◽  
V2 Receptor Antagonist

Effect of SR121463, a Selective Non-Peptide Vasopressin V2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension

2000 ◽  
Vol 16 (3) ◽  
pp. 203-216 ◽  
Author(s):  
FREDERIC LACHERETZ ◽  
ALAIN BARBIER ◽  
CLAUDINE SERRADEIL-LE GAL ◽  
PIERRE-PAUL ELENA ◽  
JEAN-PIERRE MAFFRAND ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Ocular Hypertension ◽  
Rabbit Model ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals OPC-31260, a nonpeptide vasopressin V2 receptor antagonist is a novel aquaretic agent

1992 ◽  
Vol 58 ◽  
pp. 195
Author(s):  
Shigeki Nakamura ◽  
Yoshitaka Yamamura ◽  
Hidenori Ogawa ◽  
Tomihiko Chihara ◽  
Toshiyuki Onogawa ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals FP051DETERMINANTS OF URINE VOLUME IN ADPKD-PATIENTS USING THE VASOPRESSIN V2 RECEPTOR ANTAGONIST TOLVAPTAN

2018 ◽  
Vol 33 (suppl_1) ◽  
pp. i64-i65
Author(s):  
Bart Kramers ◽  
Judith Heida ◽  
Wendy Boertien ◽  
Maatje van Gastel ◽  
Esther Meijer ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Urine Volume ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document